FDA Inspection 1168808 — Regional Women's Health Group, LLC

Regional Women's Health Group, LLC — FEI 3004088908

The FDA completed an inspection of Regional Women's Health Group, LLC on April 22, 2022 in Marlton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 22, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Marlton, NJ (United States)